These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12369989)
1. DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibition. Perry PJ; Jenkins TC Mini Rev Med Chem; 2001 May; 1(1):31-41. PubMed ID: 12369989 [TBL] [Abstract][Full Text] [Related]
2. Cyclic perylene diimide: Selective ligand for tetraplex DNA binding over double stranded DNA. Vasimalla S; Sato S; Takenaka F; Kurose Y; Takenaka S Bioorg Med Chem; 2017 Dec; 25(24):6404-6411. PubMed ID: 29089258 [TBL] [Abstract][Full Text] [Related]
3. Tetraplex binding molecules as anti-cancer agents. Doherty KM; Sharma S; Gupta R; Brosh RM Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):185-200. PubMed ID: 18221036 [TBL] [Abstract][Full Text] [Related]
4. Novel Oligopyrrole Carboxamide based Nickel(II) and Palladium(II) Salens, Their Targeting of Human G-Quadruplex DNA, and Selective Cancer Cell Toxicity. Ali A; Kamra M; Roy S; Muniyappa K; Bhattacharya S Chem Asian J; 2016 Sep; 11(18):2542-54. PubMed ID: 27604686 [TBL] [Abstract][Full Text] [Related]
5. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655 [TBL] [Abstract][Full Text] [Related]
6. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. Shi DF; Wheelhouse RT; Sun D; Hurley LH J Med Chem; 2001 Dec; 44(26):4509-23. PubMed ID: 11741471 [TBL] [Abstract][Full Text] [Related]
7. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. Kim MY; Vankayalapati H; Shin-Ya K; Wierzba K; Hurley LH J Am Chem Soc; 2002 Mar; 124(10):2098-9. PubMed ID: 11878947 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells. Maji B; Kumar K; Kaulage M; Muniyappa K; Bhattacharya S J Med Chem; 2014 Aug; 57(16):6973-88. PubMed ID: 25062468 [TBL] [Abstract][Full Text] [Related]
9. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes. Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414 [TBL] [Abstract][Full Text] [Related]
10. Stabilisation of G-quadruplex DNA by small molecules. Arola A; Vilar R Curr Top Med Chem; 2008; 8(15):1405-15. PubMed ID: 18991726 [TBL] [Abstract][Full Text] [Related]
11. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA. Maji B; Bhattacharya S Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755 [TBL] [Abstract][Full Text] [Related]
12. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition. Bhattacharya S; Chaudhuri P; Jain AK; Paul A Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245 [TBL] [Abstract][Full Text] [Related]
13. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands. Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460 [TBL] [Abstract][Full Text] [Related]
14. Quinazoline derivative from indigenous isolate, Nocardiopsis alba inhibits human telomerase enzyme. Kiran KG; Thandeeswaran M; Ayub Nawaz KA; Easwaran M; Jayagopi KK; Ebrahimi L; Palaniswamy M; Mahendran R; Angayarkanni J J Appl Microbiol; 2016 Dec; 121(6):1637-1652. PubMed ID: 27567126 [TBL] [Abstract][Full Text] [Related]
15. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556 [TBL] [Abstract][Full Text] [Related]
16. Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition. Sissi C; Lucatello L; Paul Krapcho A; Maloney DJ; Boxer MB; Camarasa MV; Pezzoni G; Menta E; Palumbo M Bioorg Med Chem; 2007 Jan; 15(1):555-62. PubMed ID: 17035038 [TBL] [Abstract][Full Text] [Related]
17. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493 [TBL] [Abstract][Full Text] [Related]